Cardiff Oncology Inc (CRDF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,326 | -11,811 | -11,566 | -2,239 | -5,260 |
| Depreciation Amortization | 484 | 131 | 42 | 10 | 20 |
| Accounts receivable | 22 | 89 | -69 | -24 | N/A |
| Other Working Capital | 438 | 1,078 | -824 | 610 | 330 |
| Other Operating Activity | 654 | 3,196 | 7,483 | -287 | 890 |
| Operating Cash Flow | $-12,727 | $-7,317 | $-4,935 | $-1,930 | $-4,020 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -300 | -649 | -270 | -2 | -130 |
| Investing Cash Flow | $-300 | $-649 | $-270 | $-2 | $-130 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 516 | N/A | N/A | N/A |
| Debt Issued | 15,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 0 | 22,468 | 15,324 | 2,574 | N/A |
| Dividend Paid | N/A | N/A | N/A | N/A | -50 |
| Other Financing Activity | -516 | 0 | 0 | 0 | 810 |
| Financing Cash Flow | $14,484 | $22,984 | $15,324 | $2,574 | $760 |
| Beginning Cash Position | 25,837 | 10,820 | 700 | 59 | 3,860 |
| End Cash Position | 27,294 | 25,837 | 10,820 | 700 | 470 |
| Net Cash Flow | $1,457 | $15,017 | $10,119 | $642 | $-3,390 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,727 | -7,317 | -4,935 | -1,930 | -4,020 |
| Capital Expenditure | -363 | -650 | -274 | -2 | N/A |
| Free Cash Flow | -13,091 | -7,967 | -5,209 | -1,932 | -4,020 |